MedPath

SAM study: An epigenetic therapy for depression after childhood trauma

Conditions
bipolar disorder
depression
DNA methylation
childhood trauma
SAMe
S-adenosyl-L-methionine
epigenetic
Registration Number
NL-OMON21753
Lead Sponsor
niversity Medical Centre Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

1.Diagnosis of bipolar disorder as defined by DSM-IV-R as determined by the SCID.

2.Age 18 -65 years.

Exclusion Criteria

1.Psychiatric admission in the past six months

2.Compulsory admission or treatment under Dutch law (BOPZ)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
50 percent reduction of 50% or more of the Hamilton Depression Rating Scale
Secondary Outcome Measures
NameTimeMethod
MADRS, genome-wide DNA methylation and KITLG methylation, Altered stress resilience
© Copyright 2025. All Rights Reserved by MedPath